Cargando…
Mutated and Bacteriophage T4 Nanoparticle Arrayed F1-V Immunogens from Yersinia pestis as Next Generation Plague Vaccines
Pneumonic plague is a highly virulent infectious disease with 100% mortality rate, and its causative organism Yersinia pestis poses a serious threat for deliberate use as a bioterror agent. Currently, there is no FDA approved vaccine against plague. The polymeric bacterial capsular protein F1, a key...
Autores principales: | Tao, Pan, Mahalingam, Marthandan, Kirtley, Michelle L., van Lier, Christina J., Sha, Jian, Yeager, Linsey A., Chopra, Ashok K., Rao, Venigalla B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3708895/ https://www.ncbi.nlm.nih.gov/pubmed/23853602 http://dx.doi.org/10.1371/journal.ppat.1003495 |
Ejemplares similares
-
A Bivalent Anthrax–Plague Vaccine That Can Protect against Two Tier-1 Bioterror Pathogens, Bacillus anthracis and Yersinia pestis
por: Tao, Pan, et al.
Publicado: (2017) -
A Bacteriophage T4 Nanoparticle-Based Dual Vaccine against Anthrax and Plague
por: Tao, Pan, et al.
Publicado: (2018) -
Identification of New Virulence Factors and Vaccine Candidates for Yersinia pestis
por: Andersson, Jourdan A., et al.
Publicado: (2017) -
Yersinia pestis halotolerance illuminates plague reservoirs
por: Malek, Maliya Alia, et al.
Publicado: (2017) -
Immunisation of two rodent species with new live-attenuated mutants of Yersinia pestis CO92 induces protective long-term humoral- and cell-mediated immunity against pneumonic plague
por: Tiner, Bethany L, et al.
Publicado: (2016)